{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T06:10:10Z","timestamp":1745561410103,"version":"3.40.4"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,24]]},"DOI":"10.7759\/cureus.82953","type":"journal-article","created":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T05:38:43Z","timestamp":1745559523000},"source":"Crossref","is-referenced-by-count":0,"title":["Serum Mitsugumin-53 Level as a Diagnostic Marker in Patients With Acute Coronary Syndrome: A Case-Control Study"],"prefix":"10.7759","author":[{"given":"Sriram M","family":"Pattabi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prashant S","family":"Adole","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kolar V","family":"Vinod","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-023-00884-0","article-title":"Global epidemiology of acute coronary syndromes","volume":"20","author":"Timmis A","year":"2023","unstructured":"Timmis A, Kazakiewicz D, Townsend N, Huculeci R, Aboyans V, Vardas P. Global epidemiology of acute coronary syndromes. Nat Rev Cardiol. 2023, 20:778-88. 10.1038\/s41569-023-00884-0","journal-title":"Nat Rev Cardiol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mjafi.2019.12.005","article-title":"Cardiovascular disease in India: a 360 degree overview","volume":"76","author":"Sreeniwas Kumar A","year":"2020","unstructured":"Sreeniwas Kumar A, Sinha N. Cardiovascular disease in India: a 360 degree overview. Med J Armed Forces India. 2020, 76:1-3. 10.1016\/j.mjafi.2019.12.005","journal-title":"Med J Armed Forces India"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2021.559751","article-title":"Global, regional, and national death, and disability-adjusted life-years (DALYs) for cardiovascular disease in 2017 and trends and risk analysis from 1990 to 2017 using the Global Burden of Disease Study and implications for prevention","volume":"9","author":"Li Z","year":"2021","unstructured":"Li Z, Lin L, Wu H, Yan L, Wang H, Yang H, Li H. Global, regional, and national death, and disability-adjusted life-years (DALYs) for cardiovascular disease in 2017 and trends and risk analysis from 1990 to 2017 using the Global Burden of Disease Study and implications for prevention. Front Public Health. 2021, 9:559751. 10.3389\/fpubh.2021.559751","journal-title":"Front Public Health"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.2147\/VHRM.S166157","article-title":"Biomarkers in acute myocardial infarction: current perspectives","volume":"15","author":"Aydin S","year":"2019","unstructured":"Aydin S, Ugur K, Aydin S, Sahin \u0130, Yardim M. Biomarkers in acute myocardial infarction: current perspectives. Vasc Health Risk Manag. 2019, 15:1-10. 10.2147\/VHRM.S166157","journal-title":"Vasc Health Risk Manag"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics11050881","article-title":"Past, present, and future of blood biomarkers for the diagnosis of acute myocardial infarction-promises and challenges","volume":"11","author":"Tilea I","year":"2021","unstructured":"Tilea I, Varga A, Serban RC. Past, present, and future of blood biomarkers for the diagnosis of acute myocardial infarction-promises and challenges. Diagnostics (Basel). 2021, 11:10.3390\/diagnostics11050881","journal-title":"Diagnostics (Basel)"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/2018035","article-title":"The biomarkers for acute myocardial infarction and heart failure","volume":"2020","author":"Wang XY","year":"2020","unstructured":"Wang XY, Zhang F, Zhang C, Zheng LR, Yang J. The biomarkers for acute myocardial infarction and heart failure. Biomed Res Int. 2020, 2020:2018035. 10.1155\/2020\/2018035","journal-title":"Biomed Res Int"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.21037\/jtd.2019.08.100","article-title":"Discovery of potential plasma protein biomarkers for acute myocardial infarction via proteomics","volume":"11","author":"Xu S","year":"2019","unstructured":"Xu S, Jiang J, Zhang Y, Chen T, Zhu M, Fang C, Mi Y. Discovery of potential plasma protein biomarkers for acute myocardial infarction via proteomics. J Thorac Dis. 2019, 11:3962-72. 10.21037\/jtd.2019.08.100","journal-title":"J Thorac Dis"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/6258865","article-title":"A review of novel cardiac biomarkers in acute or chronic cardiovascular diseases: the role of soluble ST2 (sST2), lipoprotein-associated phospholipase A2 (Lp-PLA2), myeloperoxidase (MPO), and procalcitonin (PCT)","volume":"2021","author":"Li J","year":"2021","unstructured":"Li J, Cao T, Wei Y, et al.. A review of novel cardiac biomarkers in acute or chronic cardiovascular diseases: the role of soluble ST2 (sST2), lipoprotein-associated phospholipase A2 (Lp-PLA2), myeloperoxidase (MPO), and procalcitonin (PCT). Dis Markers. 2021, 2021:6258865. 10.1155\/2021\/6258865","journal-title":"Dis Markers"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2020.583393","article-title":"Multi-cellular functions of MG53 in muscle calcium signaling and regeneration","volume":"11","author":"Benissan-Messan DZ","year":"2020","unstructured":"Benissan-Messan DZ, Zhu H, Zhong W, Tan T, Ma J, Lee PH. Multi-cellular functions of MG53 in muscle calcium signaling and regeneration. Front Physiol. 2020, 11:583393. 10.3389\/fphys.2020.583393","journal-title":"Front Physiol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2021.04.005","article-title":"Muscle multiorgan crosstalk with MG53 as a myokine for tissue repair and regeneration","volume":"59","author":"Whitson BA","year":"2021","unstructured":"Whitson BA, Tan T, Gong N, Zhu H, Ma J. Muscle multiorgan crosstalk with MG53 as a myokine for tissue repair and regeneration. Curr Opin Pharmacol. 2021, 59:26-32. 10.1016\/j.coph.2021.04.005","journal-title":"Curr Opin Pharmacol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.yjmcc.2015.01.023","article-title":"Mitsugumin-53: potential biomarker and therapeutic for myocardial ischemic injury?","volume":"81","author":"Kohr MJ","year":"2015","unstructured":"Kohr MJ. Mitsugumin-53: potential biomarker and therapeutic for myocardial ischemic injury?. J Mol Cell Cardiol. 2015, 81:46-8. 10.1016\/j.yjmcc.2015.01.023","journal-title":"J Mol Cell Cardiol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.119.044998","article-title":"Cardiac ischemic preconditioning promotes MG53 secretion through H2O2-activated protein kinase C-\u03b4 signaling","volume":"142","author":"Shan D","year":"2020","unstructured":"Shan D, Guo S, Wu HK, et al.. Cardiac ischemic preconditioning promotes MG53 secretion through H2O2-activated protein kinase C-\u03b4 signaling. Circulation. 2020, 142:1077-91. 10.1161\/CIRCULATIONAHA.119.044998","journal-title":"Circulation"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1186\/s13578-021-00629-x","article-title":"Cardiac effects and clinical applications of MG53","volume":"11","author":"Zhong W","year":"2021","unstructured":"Zhong W, Benissan-Messan DZ, Ma J, Cai C, Lee PH. Cardiac effects and clinical applications of MG53. Cell Biosci. 2021, 11:115. 10.1186\/s13578-021-00629-x","journal-title":"Cell Biosci"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.yjmcc.2014.12.010","article-title":"Cardioprotection of recombinant human MG53 protein in a porcine model of ischemia and reperfusion injury","volume":"80","author":"Liu J","year":"2015","unstructured":"Liu J, Zhu H, Zheng Y, et al.. Cardioprotection of recombinant human MG53 protein in a porcine model of ischemia and reperfusion injury. J Mol Cell Cardiol. 2015, 80:10-9. 10.1016\/j.yjmcc.2014.12.010","journal-title":"J Mol Cell Cardiol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2020.617845","article-title":"Serum MG53\/TRIM72 is associated with the presence and severity of coronary artery disease and acute myocardial infarction","volume":"11","author":"Xie H","year":"2020","unstructured":"Xie H, Wang Y, Zhu T, et al.. Serum MG53\/TRIM72 is associated with the presence and severity of coronary artery disease and acute myocardial infarction. Front Physiol. 2020, 11:617845. 10.3389\/fphys.2020.617845","journal-title":"Front Physiol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2022.0358","article-title":"Diagnosis and treatment of acute coronary syndromes: a review","volume":"327","author":"Bhatt DL","year":"2022","unstructured":"Bhatt DL, Lopes RD, Harrington RA. Diagnosis and treatment of acute coronary syndromes: a review. JAMA. 2022, 327:662-75. 10.1001\/jama.2022.0358","journal-title":"JAMA"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.2174\/157340311795677662","article-title":"Risk scores for patients with chest pain: evaluation in the emergency department","volume":"7","author":"Backus BE","year":"2011","unstructured":"Backus BE, Six AJ, Kelder JH, Gibler WB, Moll FL, Doevendans PA. Risk scores for patients with chest pain: evaluation in the emergency department. Curr Cardiol Rev. 2011, 7:2-8. 10.2174\/157340311795677662","journal-title":"Curr Cardiol Rev"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.21037\/jeccm.2018.01.10","article-title":"Clinical scores for risk stratification of chest pain patients in the emergency department: an updated systemic review","volume":"2","author":"Liu N","year":"2018","unstructured":"Liu N, Ng JC, Ting CE, et al.. Clinical scores for risk stratification of chest pain patients in the emergency department: an updated systemic review. J Emerg Crit Care Med. 2018, 2:16. 10.21037\/jeccm.2018.01.10","journal-title":"J Emerg Crit Care Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.91.6.1659","article-title":"Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction. Results from an international trial of 41,021 patients. GUSTO-I Investigators","volume":"91","author":"Lee KL","year":"1995","unstructured":"Lee KL, Woodlief LH, Topol EJ, et al.. Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction. Results from an international trial of 41,021 patients. GUSTO-I Investigators. Circulation. 1995, 91:1659-68. 10.1161\/01.cir.91.6.1659","journal-title":"Circulation"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.31083\/j.rcm2502056","article-title":"Circulating myokines as novel biomarkers for cardiovascular diseases","volume":"25","author":"Lyu JX","year":"2024","unstructured":"Lyu JX, Guo DD, Song YC, et al.. Circulating myokines as novel biomarkers for cardiovascular diseases. Rev Cardiovasc Med. 2024, 25:56. 10.31083\/j.rcm2502056","journal-title":"Rev Cardiovasc Med"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.00167.2013","article-title":"Proteomic mapping of proteins released during necrosis and apoptosis from cultured neonatal cardiac myocytes","volume":"306","author":"Marshall KD","year":"2014","unstructured":"Marshall KD, Edwards MA, Krenz M, Davis JW, Baines CP. Proteomic mapping of proteins released during necrosis and apoptosis from cultured neonatal cardiac myocytes. Am J Physiol Cell Physiol. 2014, 306:C639-47. 10.1152\/ajpcell.00167.2013","journal-title":"Am J Physiol Cell Physiol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.148375","article-title":"MG53 suppresses NF-\u03baB activation to mitigate age-related heart failure","volume":"6","author":"Wang X","year":"2021","unstructured":"Wang X, Li X, Ong H, et al.. MG53 suppresses NF-\u03baB activation to mitigate age-related heart failure. JCI Insight. 2021, 6:10.1172\/jci.insight.148375","journal-title":"JCI Insight"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2022.102357","article-title":"MG53 preserves mitochondrial integrity of cardiomyocytes during ischemia reperfusion-induced oxidative stress","volume":"54","author":"Gumpper-Fedus K","year":"2022","unstructured":"Gumpper-Fedus K, Park KH, Ma H, et al.. MG53 preserves mitochondrial integrity of cardiomyocytes during ischemia reperfusion-induced oxidative stress. Redox Biol. 2022, 54:102357. 10.1016\/j.redox.2022.102357","journal-title":"Redox Biol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.18773\/austprescr.2022.006","article-title":"Troponins in myocardial infarction and injury","volume":"45","author":"Potter JM","year":"2022","unstructured":"Potter JM, Hickman PE, Cullen L. Troponins in myocardial infarction and injury. Aust Prescr. 2022, 45:53-7. 10.18773\/austprescr.2022.006","journal-title":"Aust Prescr"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2021.36.e61","article-title":"Evaluation of heart-type fatty acid-binding protein in early diagnosis of acute myocardial infarction","volume":"36","author":"Moon MG","year":"2021","unstructured":"Moon MG, Yoon CH, Lee K, Kang SH, Youn TJ, Chae IH. Evaluation of heart-type fatty acid-binding protein in early diagnosis of acute myocardial infarction. J Korean Med Sci. 2021, 36:e61. 10.3346\/jkms.2021.36.e61","journal-title":"J Korean Med Sci"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1038\/aps.2018.37","article-title":"Heart-type fatty acid binding protein (H-FABP) as a biomarker for acute myocardial injury and long-term post-ischemic prognosis","volume":"39","author":"Ye XD","year":"2018","unstructured":"Ye XD, He Y, Wang S, Wong GT, Irwin MG, Xia Z. Heart-type fatty acid binding protein (H-FABP) as a biomarker for acute myocardial injury and long-term post-ischemic prognosis. Acta Pharmacol Sin. 2018, 39:1155-63. 10.1038\/aps.2018.37","journal-title":"Acta Pharmacol Sin"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.118.037216","article-title":"Glucose-sensitive myokine\/cardiokine MG53 regulates systemic insulin response and metabolic homeostasis","volume":"139","author":"Wu HK","year":"2019","unstructured":"Wu HK, Zhang Y, Cao CM, et al.. Glucose-sensitive myokine\/cardiokine MG53 regulates systemic insulin response and metabolic homeostasis. Circulation. 2019, 139:901-14. 10.1161\/CIRCULATIONAHA.118.037216","journal-title":"Circulation"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0291333","article-title":"Association of MG53 with presence of type 2 diabetes mellitus, glycemic control, and diabetic complications","volume":"18","author":"Anda\u00e7 B","year":"2023","unstructured":"Anda\u00e7 B, \u00d6zg\u00fcn E, B\u00fclb\u00fcl BY, et al.. Association of MG53 with presence of type 2 diabetes mellitus, glycemic control, and diabetic complications. PLoS One. 2023, 18:e0291333. 10.1371\/journal.pone.0291333","journal-title":"PLoS One"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2020.596107","article-title":"Prognostic value of circulating MG53 levels in acute myocardial infarction","volume":"7","author":"Xie H","year":"2020","unstructured":"Xie H, Yan Z, Feng S, et al.. Prognostic value of circulating MG53 levels in acute myocardial infarction. Front Cardiovasc Med. 2020, 7:596107. 10.3389\/fcvm.2020.596107","journal-title":"Front Cardiovasc Med"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2023.110916","article-title":"MG53 does not mark cardiovascular risk and all-cause mortality in subjects with type 2 diabetes: a prospective, observational study","volume":"204","author":"Bianchi C","year":"2023","unstructured":"Bianchi C, Vaccaro O, Distaso M, Franzini L, Raggi F, Solini A. MG53 does not mark cardiovascular risk and all-cause mortality in subjects with type 2 diabetes: a prospective, observational study. Diabetes Res Clin Pract. 2023, 204:110916. 10.1016\/j.diabres.2023.110916","journal-title":"Diabetes Res Clin Pract"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/359784-serum-mitsugumin-53-level-as-a-diagnostic-marker-in-patients-with-acute-coronary-syndrome-a-case-control-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T05:38:44Z","timestamp":1745559524000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/359784-serum-mitsugumin-53-level-as-a-diagnostic-marker-in-patients-with-acute-coronary-syndrome-a-case-control-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,24]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.82953","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4,24]]}}}